Triparna Sen: DDR protein ATR activation enhances immunotherapy in SCLC
Triparna Sen posted the following on X:
“Thank you Icahn School of Medicine at Mount Sinai, Tisch Cancer Institute for the press release of our work now published in Science Advances demonstrating that targeting DDR protein ATR activates the cGAS-STING pathway, induces immune cell infiltration, and enhances response to immunotherapy in SCLC. a very aggressive form of lung cancer.
Link to the paper.
Press release.
See thread for further details.”
Authors: Hirokazu Taniguchi, Subhamoy Chakraborty, Nobuyuki Takahashi, Avisek Banerjee, Rebecca Caeser, Yingqian A Zhan, Sam E Tischfield, Andrew Chow, Evelyn M Nguyen, Álvaro Quintanal Villalonga, Parvathy Manoj, Nisargbhai S Shah, Samantha Rosario, Omar Hayatt, Rui Qu, Elisa de Stanchina, Joseph Chan, Hiroshi Mukae, Anish Thomas, Charles M Rudin, Triparna Sen.
Source: Triparna Sen/X
Triparna Sen is an Associate Professor at the Icahn School of Medicine at Mount Sinai. She was previously an assistant attending at the Memorial Sloan Kettering Cancer Center. She also served as a research associate at Indian Institute of Chemical Biology.
-
ESMO 2024 Congress
September 13-17, 2024
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023